These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 31663477)

  • 1. In vivo Antiplasmodial Activity of Curcumin-Loaded Nanostructured Lipid Carriers.
    Rashidzadeh H; Salimi M; Sadighian S; Rostamizadeh K; Ramazani A
    Curr Drug Deliv; 2019; 16(10):923-930. PubMed ID: 31663477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanostructured lipid carriers enhance the bioavailability and brain cancer inhibitory efficacy of curcumin both in vitro and in vivo.
    Chen Y; Pan L; Jiang M; Li D; Jin L
    Drug Deliv; 2016 May; 23(4):1383-92. PubMed ID: 26066035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustained-release liquisolid compact tablets containing artemether-lumefantrine as alternate-day regimen for malaria treatment to improve patient compliance.
    Nnamani PO; Ugwu AA; Ibezim EC; Kenechukwu FC; Akpa PA; Ogbonna JN; Obitte NC; Odo AN; Windbergs M; Lehr CM; Attama AA
    Int J Nanomedicine; 2016; 11():6365-6378. PubMed ID: 27932882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curcumin-loaded nanostructured lipid carriers prepared using Peceol™ and olive oil in photodynamic therapy: development and application in breast cancer cell line.
    Kamel AE; Fadel M; Louis D
    Int J Nanomedicine; 2019; 14():5073-5085. PubMed ID: 31371948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curcumin-guided nanotherapy: a lipid-based nanomedicine for targeted drug delivery in breast cancer therapy.
    Lin M; Teng L; Wang Y; Zhang J; Sun X
    Drug Deliv; 2016 May; 23(4):1420-5. PubMed ID: 26203688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative study on the efficiency of chitosan-N-acetylcysteine, chitosan oligosaccharides or carboxymethyl chitosan surface modified nanostructured lipid carrier for ophthalmic delivery of curcumin.
    Li J; Liu D; Tan G; Zhao Z; Yang X; Pan W
    Carbohydr Polym; 2016 Aug; 146():435-44. PubMed ID: 27112894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-delivery of etoposide and curcumin by lipid nanoparticulate drug delivery system for the treatment of gastric tumors.
    Jiang H; Geng D; Liu H; Li Z; Cao J
    Drug Deliv; 2016 Nov; 23(9):3665-3673. PubMed ID: 27749102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic studies and anticancer activity of curcumin-loaded nanostructured lipid carriers.
    Wang F; Chen J; Dai W; He Z; Zhai D; Chen W
    Acta Pharm; 2017 Sep; 67(3):357-371. PubMed ID: 28858837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Curcumin loaded NLC induces histone hypoacetylation in the CNS after intraperitoneal administration in mice.
    Puglia C; Frasca G; Musumeci T; Rizza L; Puglisi G; Bonina F; Chiechio S
    Eur J Pharm Biopharm; 2012 Jun; 81(2):288-93. PubMed ID: 22504443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ameliorating the in vivo antimalarial efficacy of artemether using nanostructured lipid carriers.
    Vanka R; Kuppusamy G; Praveen Kumar S; Baruah UK; Karri VVSR; Pandey V; Babu PP
    J Microencapsul; 2018 Mar; 35(2):121-136. PubMed ID: 29448884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and characterization of nanostructured lipid carriers as drug delivery system: Influence of liquid lipid types on loading and cytotoxicity.
    Saedi A; Rostamizadeh K; Parsa M; Dalali N; Ahmadi N
    Chem Phys Lipids; 2018 Nov; 216():65-72. PubMed ID: 30219661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-acetyl-L-cysteine functionalized nanostructured lipid carrier for improving oral bioavailability of curcumin: preparation, in vitro and in vivo evaluations.
    Tian C; Asghar S; Wu Y; Kambere Amerigos D; Chen Z; Zhang M; Yin L; Huang L; Ping Q; Xiao Y
    Drug Deliv; 2017 Nov; 24(1):1605-1616. PubMed ID: 29063815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential advantages of a novel chitosan-N-acetylcysteine surface modified nanostructured lipid carrier on the performance of ophthalmic delivery of curcumin.
    Liu D; Li J; Pan H; He F; Liu Z; Wu Q; Bai C; Yu S; Yang X
    Sci Rep; 2016 Jun; 6():28796. PubMed ID: 27350323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and in vitro evaluation of glycyrrhetinic acid-modified curcumin-loaded nanostructured lipid carriers.
    Chu Y; Li D; Luo YF; He XJ; Jiang MY
    Molecules; 2014 Feb; 19(2):2445-57. PubMed ID: 24566313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of artemether and lumefantrine co-loaded nanostructured lipid carriers: physicochemical characterization and in vivo antimalarial activity.
    Parashar D; Aditya NP; Murthy RS
    Drug Deliv; 2016; 23(1):123-9. PubMed ID: 24786480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving intestinal absorption and oral bioavailability of curcumin via taurocholic acid-modified nanostructured lipid carriers.
    Tian C; Asghar S; Wu Y; Chen Z; Jin X; Yin L; Huang L; Ping Q; Xiao Y
    Int J Nanomedicine; 2017; 12():7897-7911. PubMed ID: 29138557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, characterization and in vivo evaluation of nanostructured lipid carriers (NLC) as a new drug delivery system for hydrochlorothiazide oral administration in pediatric therapy.
    Cirri M; Maestrini L; Maestrelli F; Mennini N; Mura P; Ghelardini C; Di Cesare Mannelli L
    Drug Deliv; 2018 Nov; 25(1):1910-1921. PubMed ID: 30451015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted Nanostructured Lipid Carrier for Brain Delivery of Artemisinin: Design, Preparation, Characterization, Optimization and Cell Toxicity.
    Emami J; Yousefian H; Sadeghi H
    J Pharm Pharm Sci; 2018; 21(1s):225s-241s. PubMed ID: 30266137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Artemisinin and artemisinin plus curcumin liposomal formulations: enhanced antimalarial efficacy against Plasmodium berghei-infected mice.
    Isacchi B; Bergonzi MC; Grazioso M; Righeschi C; Pietretti A; Severini C; Bilia AR
    Eur J Pharm Biopharm; 2012 Apr; 80(3):528-34. PubMed ID: 22142592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and optimization of sulforaphane-loaded nanostructured lipid carriers by the Box-Behnken design for improved oral efficacy against cancer: in vitro, ex vivo and in vivo assessments.
    Soni K; Rizwanullah M; Kohli K
    Artif Cells Nanomed Biotechnol; 2018; 46(sup1):15-31. PubMed ID: 29183147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.